Horseshoe Crabs, Living Fossils of the Sea, Draw Endangered Species Petition 

Atlantic Horseshoe crabs come ashore to spawn and lay their eggs on Pickering Beach, a national horseshoe crab sanctuary near Little Creek, Delaware, May 20, 2008. (Reuters)
Atlantic Horseshoe crabs come ashore to spawn and lay their eggs on Pickering Beach, a national horseshoe crab sanctuary near Little Creek, Delaware, May 20, 2008. (Reuters)
TT

Horseshoe Crabs, Living Fossils of the Sea, Draw Endangered Species Petition 

Atlantic Horseshoe crabs come ashore to spawn and lay their eggs on Pickering Beach, a national horseshoe crab sanctuary near Little Creek, Delaware, May 20, 2008. (Reuters)
Atlantic Horseshoe crabs come ashore to spawn and lay their eggs on Pickering Beach, a national horseshoe crab sanctuary near Little Creek, Delaware, May 20, 2008. (Reuters)

Environmental groups on Monday petitioned the US government seeking endangered species protection for the American horseshoe crab, a "living fossil" under threat from commercial harvests for bait and biomedical use as well as from habitat loss and climate change.

These spine-tailed sea creatures named for the shape of their body shells have been crawling ashore since long before the age of dinosaurs, and in modern times were a familiar sight to summer beachgoers along the US mid-Atlantic and Gulf Coasts.

But horseshoe crab populations have crashed in recent decades, with spawning numbers down two-thirds from 1990 in the Delaware Bay estuary that was once their biggest stronghold, according to conservation groups. Research also shows their egg densities falling more than 80% in the past four decades.

Those trends are tied to stress on other marine species that feed on their larvae and eggs, including the rufa red knot, a migratory shorebird whose own 2014 threatened-species listing cited horseshoe crab harvests as a contributing factor.

Classified not as true crabs but as marine arthropods most closely related to spiders and scorpions, horseshoe crabs are among the oldest living creatures on Earth, with fossils of their ancestors dating back some 450 million years.

Despite their primitive appearance, horseshoe crabs are harmless to people, for whom encounters were once common along shorelines where the animals congregated each spring to lay million eggs.

Now, after surviving several mass-extinction events through the ages, including an asteroid impact 66 million years ago that killed off dinosaurs, the lowly horseshoe crab is facing its own demise from a combination of human activities.

"We're wiping out one of the world's oldest and toughest creatures," said Will Harlan, a senior scientist at the Center for Biological Diversity, one of 23 groups petitioning the National Oceanic and Atmospheric Administration (NOAA) for the endangered species declaration.

Such a listing would generally make it unlawful to harm or kill a horseshoe crab without a special permit. The petition also seeks designation of "critical habitat" to be protected, especially during spawning season.

NOAA Fisheries spokesperson said the agency would review the petition, but declined further comment.

The petition cites numerous threats to the American horseshoe crab, one of four living species of the animal, stemming from human activities.

Pharmaceutical companies reap horseshoe crabs in large numbers - nearly 1 million in 2022 - for their blue-colored blood, which contains a clotting agent used to test drugs and medical devices for bacterial endotoxins, the petition said.

Regulations allow the biomedical industry to extract only a portion of a horseshoe crab's blood and then release it alive in the area it was collected, though 10-15% of harvested animals die during this process, NOAA says on its website.

Harlan said non-industry research shows about 30% of horseshoe crabs collected for blood extraction die in the process. He added that synthetic alternatives are widely used in Europe, but US companies have been slow to adopt them.

Over-harvesting of horseshoe crabs as bait for commercial whelk and eel fisheries has further decimated their numbers, with no sign of recovery even after quotas were imposed, according to the petition.

The creatures also face growing habitat loss from oceanfront development, dredging, pollution, coastal erosion and sea-level rise linked to global warming from increased greenhouse gas emissions.

Mass die-offs have been observed in the past three years, with NOAA in 2023 ranking the horseshoe crab's overall vulnerability to climate change as "very high," the petition said.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”